Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis

Tuberculosis

Volumn 85, Issue 1-2 SPEC.ISS., 2005, Pages 29-38

  Williams, Ann ^a   Hatch, Graham J ^a   Clark, Simon O ^a   Gooch, Karen E ^a   Hatch, Kim A ^a   Hall, Graham A ^a   Huygen, Kris ^b   Ottenhoff, Tom H M ^c   Franken, Kees L M C ^c   Andersen, Peter ^d   Doherty, T Mark ^d   Kaufmann, Stefan H E ^e   Grode, Leander ^e   Seiler, Peter ^e   Martin, Carlos ^f   Gicquel, Brigitte ^g   Cole, Stewart T ^g   Brodin, Priscille ^g   Pym, Alexander S ^h   Dalemans, Wilfried ⁱ   Cohen, Joe ⁱ   Lobet, Yves ⁱ   Goonetilleke, Nilu ^j   McShane, Helen ^j   Hill, Adrian ^j   Parish, Tanya ^k   Smith, Debbie ^l   Stoker, Neil G ^m   Lowrie, Douglas B ⁿ   Källenius, Gunilla ^o   Svenson, Stefan ^o   Pawlowski, Andrzej ^o   Blake, Karen ^a   Marsh, Philip D ^a   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d STATENS SERUM INSTITUT   (Denmark)

^e Department of Immunology ^*  (Germany)

^f UNIVERSITY OF ZARAGOZA   (Spain)

^g INSTITUT PASTEUR   (France)

^h LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

ⁱ GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^m ROYAL VETERINARY COLLEGE   (United Kingdom)

ⁿ NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^o KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Aerosol; Guinea pig; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; DNA VACCINE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; MYCOBACTERIUM VACCINE; RECOMBINANT VACCINE; TETANUS TOXOID;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DNA MODIFICATION; DRUG DESIGN; DRUG EFFICACY; EXPERIMENTAL INFECTION; GUINEA PIG; HISTOPATHOLOGY; INFECTION PREVENTION; LUNG TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SPECIES COMPARISON; SURVIVAL RATE;

EID: 20144389346     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2004.09.009     Document Type: Article

References (24)

1. P. Andersen TB vaccines progress and problems Trends Immunol 22 2001 160 168
2. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, 3rd., Tekaia F, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
3. A. Williams, A. Davies, P.D. Marsh, M.A. Chambers, and R.G. Hewinson Comparison of the protective efficacy of Bacille Calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis Clin Infect Dis 30 Suppl 3 2000 S299 S301
4. M.A. Chambers, A. Williams, D. Gavier-Widen, A. Whelan, G. Hall, P.D. Marsh, B.R. Bloom, W.R. Jacobs, and R.G. Hewinson Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin Infect Immun 68 2000 7094 7099
5. M.S. Lever, A. Williams, and A.M. Bennett Survival of mycobacterial species in aerosols generated from artificial saliva Lett Appl Microbiol 31 2000 238 241
6. M. Chambers, A. Williams, D. Gavier-Widen, A. Whelan, C. Hughes, G. Hall, M. Lever, P. Marsh, and R. Hewinson A guinea pig model of low-dose Mycobacterium bovis aerogenic infection Vet Microbiol 80 2001 213 226
7. Olsen AW, Williams A, Okkels LM, Hatch GJ, Andersen P. Evaluation of a tuberculosis subunit vaccine based on a fusion of Ag85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 2004, in press.
8. A.S. Pym, P. Brodin, L. Majlessi, R. Brosch, C. Demangel, A. Williams, K.E. Griffiths, G. Marchal, and C. Leclerc Cole ST Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis Nat Med 9 2003 533 539
9. Martin C, Williams A, Hernandez-Pando R, Cardona PJ, Gormley E, Bordat Y, Soto CY, Clark SO, Hatch GJ, Aguilar D, Ausina V, Gicquel B. The highly attenuated Mycobacterium tuberculosis phoP confers superior protection against tuberculosis when compared to Mycobacterium bovis BCG. Nat Med, submitted for publication.
10. P. Brodin, L. Majlessi, R. Brosch, D. Smith, G. Bancroft, S. Clark, A. Williams, C. Leclerc, and S.T. Cole Enhanced protection against extrapulmonary tuberculosis with an attenuated live Mycobacterium microti vaccine inducing T-cell immunity against RD1 antigens J Infect Dis 190 2004 115 122
11. Williams A, Goonetilleke NP, McShane H, Clark SO, Hatch GJ, Gilbert SC, Hill AVS. Boosting with poxviruses enhances BCG efficacy against tuberculosis in guinea-pigs. Infect Immun, submitted for publication.
12. M.A. Horwitz, G. Harth, B.J. Dillon, and S. Maslesa-Galic Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proc Natl Acad Sci USA 97 2000 13853 13858
13. E.H. Wiegeshaus, D.N. McMurray, A.A. Grover, G.E. Harding, and D.W. Smith Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs Am Rev Respir Dis 102 1970 422 429
14. H. McShane, S. Behboudi, N. Goonetilleke, R. Brookes, and A.V. Hill Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)-and CD4(+)-T-cell epitopes from antigen 85A Infect Immun 3 2002 1623 1626
15. D.B. Lowrie, R.E. Tascon, V.L. Bonato, V.M. Lima, L.H. Faccioli, E. Stavropoulos, M.J. Colston, R.G. Hewinson, K. Moelling, and C.L. Silva Therapy of tuberculosis in mice by DNA vaccination Nature 400 1999 269 271
16. B. Hamasur, G. Källenius, and S. Svenson Synthesis and immunologic characterization of Mycobacterium tuberculosis lipoarabinomannan specific oligosaccharide-protein conjugates Vaccine 17 1999 2853 2861
17. B. Hamasur, M. Haile, A. Pawlowski, U. Schröder, A. Williams, G. Hatch, G. Hall, P. Marsh, G. Källenius, and S. Svenson Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis Vaccine 21 2003 4081 4093
18. Haile M, Hamasur B, Jaxmar T, Gavier-Widen D, Chambers MA, Sanchez B, Schröder U, Källenius G, Svenson SB, Pawlowski A. Heat killed BCG and arabinomannan-protein conjugates in Eurocine L3adjuvant as nasal booster vaccines against tuberculosis. Tuberculosis 2004.
19. A. Tanghe, S. D'Souza, V. Rosseels, O. Denis, T.H. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting Infect Immun 69 2001 3041 3047
20. S. D'Souza, V. Rosseels, O. Denis, A. Tanghe, N. De Smet, F. Jurion, K. Palfliet, N. Castiglioni, A. Vanonckelen, C. Wheeler, and K. Huygen Improved tuberculosis DNA vaccines by formulation in cationic lipids Infect Immun 70 2002 3681 3688
21. D. Smith, T. Parish, N. Stoker, and G. Bancroft Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates Infect Immun 69 2001 1142 1150
22. T. Parish, B. Gordhan, R. McAdam, K. Duncan, V. Mizrahi, and N. Stoker Production of mutants in amino acid biosynthesis genes of Mycobacterium tuberculosis by homologous recombination Microbiology 145 1999 3497 3503
23. J. Hess, D. Miko, A. Catic, V. Lehmensiek, D.G. Russell, and S.H.E. Kaufmann Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes Proc Natl Acad Sci USA 95 1998 5299 5304
24. E. Perez, S. Samper, Y. Bordas, C. Guilhot, B. Gicquel, and C. Martin An essential role for phoP in Mycobacterium tuberculosis virulence Mol Microbiol 41 2001 179 187